CompletedEUCTR 2015-002007-29

A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects with Major Depressive Di...

This historical record does not confirm current site availability.

Historical research recordSpain + United KingdomDepression

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Spain · United Kingdom
Study phase: Phase 2

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: 140
Sponsor: Janssen-Cilag International NV
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: United Kingdom, Spain
Age range: Not clearly listed
Official registry ID: EUCTR 2015-002007-29
Official title: Show the full official title
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects with Major Depressive Di...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Spain · United Kingdom

Registry details

Historical country statuses

Spain — Completed
United Kingdom — Completed

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag International NV.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me